n,n'-bis(salicylideneamino)ethane-manganese(ii) has been researched along with Diabetes Mellitus, Type 2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, LH; Jin, Y; Li, L; Lu, CM; Xie, MJ; Yang, JR; Zhao, QH; Zhou, J; Zhu, MR | 1 |
Bahramikia, S; Yazdanparast, R | 1 |
2 other study(ies) available for n,n'-bis(salicylideneamino)ethane-manganese(ii) and Diabetes Mellitus, Type 2
Article | Year |
---|---|
A manganese-salen complex as dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Topics: Animals; Blood Glucose; Coordination Complexes; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Ethylenediamines; Glucose Tolerance Test; Humans; Mice; Mice, Inbred NOD; Molecular Docking Simulation; Organometallic Compounds; Schiff Bases | 2018 |
Inhibition of human islet amyloid polypeptide or amylin aggregation by two manganese-salen derivatives.
Topics: Amyloid; Anilino Naphthalenesulfonates; Antioxidants; Benzothiazoles; Cell Line, Tumor; Cell Survival; Diabetes Mellitus, Type 2; Ethylenediamines; Fluorescent Dyes; Humans; Islet Amyloid Polypeptide; Microscopy, Electron, Transmission; Molecular Docking Simulation; Neuroblastoma; Organometallic Compounds; Salicylates; Thiazoles | 2013 |